PD-0908 PSA Progression and survival in mCRPC patients treated with abiraterone or enzalutamide. (August 2021)

• Record Type: Journal Article
• Authors: Lopez Campos, F.; Lorente, D.; Llacer, C.; érez, P.; Gómez-Iturriaga, A.; Henriquez-López, I.; Peleteiro, P.; Ramirez-Backhaus, M.; Navarro-Castellón, J.; Lozano, R.; Romero, N.; Gajate, P.; Ana, C.; Gómez, J.; Álvarez, S.; Molina-Cerrillo, J.; Pelari, L.; Hernández-Corrales, A.; Morillo, V.; García, R.; Ferrer-Albiach, C.; Castro, E.; Olmos, D.
• Is Part Of: Radiotherapy and oncology. Volume 161(2021)supplement
• Page Start: S750
• Page End: S751
• Publication Date: 2021-08
• Subjects: Oncology -- Periodicals; Radiotherapy -- Periodicals; Tumors -- Periodicals; Medical Oncology -- Periodicals; Neoplasms -- radiotherapy -- Periodicals; Radiotherapy -- Periodicals; Radiothérapie -- Périodiques; Cancérologie -- Périodiques; Tumeurs -- Périodiques; Electronic journals; 616.9940642
• DOI: 10.1016/S0167-8140(21)07187-5
• Languages: English
• ISSNs: 0167-8140